Enteris BioPharma Presents Data from Two Clinical Studies Involving Oral Formulations of Leuprolide at ENDO 2022 Annual Conference

/PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a...

Related Keywords

Enteris Biopharma ,Enteri Peptelligence ,Gary Shangold ,Endocrine Society ,Enteris Biopharma Inc ,Gonadal Steroids Following Oral Administration Of Leuprolide ,Moral Administration ,Prnewswire Enteris Biopharma Inc ,Holdings Corporation Nasdaq ,Gonadal Steroids Following Oral Administration ,Enteris Chief Medical Officer ,Monday June ,Nc ,